Newsroom

Sorted by: Latest

-

Western Alliance Bank Named #1 Best Bank in Arizona on Forbes 2026 Best-In-State Banks List

PHOENIX--(BUSINESS WIRE)--Western Alliance Bank (NYSE: WAL) today announced that it has been named to the Forbes 2026 America’s Best-in-State Banks List, ranking #1 in Arizona and standing as the only Arizona-based bank included. In its ninth year, the Forbes Best-In-State Banks list is among the industry’s most prestigious recognitions. In partnership with market research firm Statista, Forbes surveyed 26,000 U.S. consumers and analyzed more than 1.2 million public online reviews collected bet...
-

NFL Biosciences Announces the Successful Manufacturing of a GMP Clinical Batch of NFL-102 and Validates Its Industrial Production Chain

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), a biopharmaceutical company developing innovative botanical drugs for the treatment of addictions, announces today the successful manufacturing of a GMP (Good Manufacturing Practice) clinical batch of NFL-102, a new drug candidate for smoking cessation. The analytical controls performed on this batch confirmed its compliance with the expected specifications. This achievement en...
-

NFL Biosciences annonce la fabrication avec succès d’un lot clinique GMP de NFL-102 et valide sa chaîne industrielle de production

MONTPELLIER, France--(BUSINESS WIRE)--Regulatory News: NFL BIOSCIENCES (Euronext Growth Paris – FR0014003XT0 – ALNFL), société biopharmaceutique développant des médicaments botaniques innovants pour le traitement des addictions, annonce aujourd’hui la fabrication avec succès d’un lot clinique GMP (Good Manufacturing Practice) de NFL-102, un nouveau candidat médicament destiné au sevrage tabagique. Les contrôles analytiques réalisés sur ce lot ont confirmé sa conformité aux spécifications attend...
-

Evolution de la gouvernance d’emeis : nominations au sein du comité de direction

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: Après plus de quatre années de profonde transformation, emeis (Paris:EMEIS) franchit une nouvelle étape. Grâce à l’engagement remarquable des équipes, emeis a retrouvé une trajectoire et une dynamique durables. Aujourd’hui, fort de fondations solides, Laurent Guillot, Directeur Général, fait évoluer son organisation afin d’accompagner la croissance et de poursuivre l’amélioration de la qualité de l’accompagnement des patients, des résidents, de...
-

Changes to emeis’ Governance: Appointments to the Executive Committee

PUTEAUX, France--(BUSINESS WIRE)--Regulatory News: After four years of profound transformation, emeis is entering a new chapter. Thanks to the remarkable commitment of the teams, emeis (Paris:EMEIS) has found itself on a sustainable path with good momentum. Today, building on these solid foundations, Laurent Guillot, Chief Executive Officer, is making changes to emeis’ organisational structure in order to support further growth and continue to improve the quality of care provided to patients, r...
-

Feinstein Institutes secures $4.9M in NIH grants to advance research in acute inflammation and Alzheimer’s disease

MANHASSET, N.Y.--(BUSINESS WIRE)--Tackling two of medicine’s most pressing challenges – acute inflammation and Alzheimer’s disease – Northwell Health’s Feinstein Institutes for Medical Research has successfully acquired $4.9 million in new multi-year grant funding from the National Institutes of Health (NIH). These significant awards will fuel two distinct research projects focused on unraveling fundamental biological mechanisms of acute inflammation and Alzheimer’s disease. The two grants have...
-

Operation HOPE Releases 2025 Annual Report Highlighting Record-Breaking Growth and Transformative Client Results

ATLANTA--(BUSINESS WIRE)--Operation HOPE, a national nonprofit dedicated to helping low-and moderate-income Americans thrive in an ever-changing economy, today announced the release of its 2025 Annual Report. Operation HOPE continued its impressive streak of growth by serving a record number of clients, growing its portfolio of top-tier partner organizations, and improving client outcomes with improved credit scores, increased savings and decreased levels of debt. Operation HOPE uses its HOPE I...
-

Notification of availability of Rémy Cointreau 2025-26 Universal Registration Document

PARIS--(BUSINESS WIRE)--Regulatory News: Rémy Cointreau (Paris:RCO): Rémy Cointreau's 2025-26 Universal Registration Document was filed with the French Financial Markets Authority (AMF) in the European Single Electronic Format (ESEF) on Tuesday, June 30, 2026, under the reference number D.26-0496. The document is publicly available under the current regulatory conditions and can be accessed on Rémy Cointreau's website at www.remy-cointreau.com, in both French and English, within the Finance / P...
-

Notification de mise à disposition par Rémy Cointreau du Document d’Enregistrement Universel 2025-26

PARIS--(BUSINESS WIRE)--Regulatory News: Rémy Cointreau (Paris:RCO): Le document d’enregistrement universel 2025-26 de Rémy Cointreau a été déposé auprès de l’Autorité des marchés financiers (AMF) au format ESEF (European Single Electronic Format) le mardi 30 juin 2026, sous le numéro D.26-0496. Il est tenu à la disposition du public dans les conditions prévues par la réglementation en vigueur et peut être consulté sur le site internet de la société (www.remy-cointreau.com, rubrique Finance / p...
-

Medisca在创始人Antonio Dos Santos的引领下开启发展新篇章

蒙特利尔--(BUSINESS WIRE)--(美国商业资讯)-- 超过35年来,Dos Santos一直致力于将Medisca塑造成药物配制领域的全球领导者。作为首席执行官,他将主导公司的长期战略,重点拓展Medisca的全球业务版图,投资新的增长领域,加强战略合作伙伴关系,并持续推动医疗保健专业人士每日所依赖的产品、服务、教育和专业知识的发展。 Medisca创始人兼首席执行官Antonio Dos Santos表示:“创立Medisca时,我的愿景是为行业带来制药级的品质,让医疗保健专业人士能够获得所需的产品、知识和创新,从而提供更好的患者护理,以此提升药物配制的标准。这一宗旨始终指引着我们。在我们开启新篇章之际,我们将继续投资于我们的员工、合作伙伴以及将有助于塑造Medisca和药物配制行业未来的创新。” Dos Santos将与副董事长Maria Zaccardo及Medisca的高管团队并肩工作,在Medisca持续全球扩张和投资于长期增长的过程中,继续引领公司的战略方向。 Medisca副董事长Maria Zaccardo表示:“三十多年来,Medisca在坚守自身宗旨的...